Dongdong Peng
机构：Guangzhou Institutes of Biomedicine and Health, University of Hong Kong
发表论文 3 篇 · 总被引 58 次 · h-index 2
代表论文
- Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinoma (2024 · Molecular Therapy Oncology · 被引 35)
- DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity (2025 · Science Immunology · 被引 23)
- Chimeric antigen receptor T cell targeting CD44E variant in HCC holds therapeutic potential (2026 · Molecular Therapy Oncology)